AT261293B - Verfahren zur Herstellung einer wasserlöslichen Zubereitungsform des 3,5-Dinitro-o-toluamids - Google Patents

Verfahren zur Herstellung einer wasserlöslichen Zubereitungsform des 3,5-Dinitro-o-toluamids

Info

Publication number
AT261293B
AT261293B AT397765A AT397765A AT261293B AT 261293 B AT261293 B AT 261293B AT 397765 A AT397765 A AT 397765A AT 397765 A AT397765 A AT 397765A AT 261293 B AT261293 B AT 261293B
Authority
AT
Austria
Prior art keywords
toluamide
dinitro
production
water
preparation form
Prior art date
Application number
AT397765A
Other languages
English (en)
Original Assignee
Boehringer & Soehne Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer & Soehne Gmbh filed Critical Boehringer & Soehne Gmbh
Application granted granted Critical
Publication of AT261293B publication Critical patent/AT261293B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
AT397765A 1964-05-02 1965-04-30 Verfahren zur Herstellung einer wasserlöslichen Zubereitungsform des 3,5-Dinitro-o-toluamids AT261293B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB76617A DE1209700B (de) 1964-05-02 1964-05-02 Verfahren zur Herstellung einer wasserloeslichen Zubereitungsform des 3, 5-Dinitro-o-toluamids

Publications (1)

Publication Number Publication Date
AT261293B true AT261293B (de) 1968-04-10

Family

ID=6979159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT397765A AT261293B (de) 1964-05-02 1965-04-30 Verfahren zur Herstellung einer wasserlöslichen Zubereitungsform des 3,5-Dinitro-o-toluamids

Country Status (9)

Country Link
AT (1) AT261293B (de)
BE (1) BE663315A (de)
DE (1) DE1209700B (de)
DK (1) DK105824C (de)
GB (1) GB1032406A (de)
IL (1) IL23427A (de)
LU (1) LU48505A1 (de)
NL (1) NL6505533A (de)
SE (1) SE303569B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2526986A1 (de) * 1974-06-19 1976-01-08 Merck & Co Inc Waessrige rafoxanidpraeparate

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024151A1 (en) * 2002-09-13 2004-03-25 New Pharma Research Sweden Ab Composition and potentiating method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2526986A1 (de) * 1974-06-19 1976-01-08 Merck & Co Inc Waessrige rafoxanidpraeparate

Also Published As

Publication number Publication date
SE303569B (de) 1968-09-02
LU48505A1 (de) 1965-06-29
IL23427A (en) 1968-08-22
NL6505533A (de) 1965-11-03
DK105824C (da) 1966-11-14
GB1032406A (en) 1966-06-08
DE1209700B (de) 1966-01-27
BE663315A (de) 1965-11-03

Similar Documents

Publication Publication Date Title
AT299457B (de) Verfahren zur Herstellung einer neuen Komplexverbindung des Inosins
CH451103A (de) Verfahren zur Herstellung von 1,4-Dichlortetrafluorbenzol
CH472422A (de) Verfahren zur Herstellung substituierter 1,2-Benzisothiazol-1,1-dioxyde
AT257570B (de) Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol
CH544121A (de) Verfahren zur Herstellung einer wasserlöslichen komplexen Assoziation
AT273636B (de) Verfahren zur Herstellung eines Präparates mit Fleischgeschmack
AT261293B (de) Verfahren zur Herstellung einer wasserlöslichen Zubereitungsform des 3,5-Dinitro-o-toluamids
AT256798B (de) Verfahren zur Herstellung von 2,2,3-Trichlorbutan
AT295449B (de) Verfahren zur Herstellung einer neuen Carboxypeptidase
AT284476B (de) Verfahren zur Herstellung einer Nickel-Titan-Legierung
CH471782A (de) Verfahren zur Herstellung eines neuen, substituierten 2,3-Pyridindiols
CH451171A (de) Verfahren zur Herstellung von 1,3,4-Oxdiazolen
CH466250A (de) Verfahren zur Herstellung von a,a,a&#39;,a&#39;-Tetramethyl-xylylen-dicarbinolen
AT286497B (de) Verfahren zur Herstellung einer Vaccine
AT269700B (de) Verfahren zur Herstellung einer hochdehnungsfähigen Textilware
CH460503A (de) Verfahren zur Herstellung eines Bakterienpräparates
CH468347A (de) Verfahren zur Herstellung von a,w-Diaminoalkancarbonsäuren
AT260205B (de) Verfahren zur Herstellung von 2,2,6,6-Tetrachlorcylochexanon
CH467244A (de) Verfahren zur Herstellung von L-a-Methyl-(3,4-disubstituierten-phenyl)-alaninen
AT257071B (de) Verfahren zur Herstellung des neuen 3-Oxo-17β-hydroxy-17α-methylöstra-4, 9, 11-triens
CH435237A (de) Verfahren zur Herstellung von Dimethyläther-a,a&#39;-tetrasubstituierten-a-Mononitril-a&#39;-monocarbonsäuren
AT292195B (de) Verfahren zur Herstellung einer Vaccine
CH484140A (de) Verfahren zur Herstellung von 2-Oxo-7-phenyl-1,2,3,4,6,7-hexahydro-11bH-benzo(a)chinolizinen
AT278746B (de) Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol
CH459191A (de) Verfahren zur Herstellung von 17a-substituierten 1,1-Äthylen- 2-5a-androsten-17B-olen